Result Calendar 08.02.2023 at a Glance

3MINDIA, ADANIPOWER, AWL, CUMMINSIND, DREAMFOLKS, ENDURANCE, EQUITASBNK, ESCORTS, GATI, GOCLCORP, GODREJAGRO, GPPL, GRAPHITE, HGINFRA, HINDMOTORS, IMAGICAA, INDIAGLYCO, INDRAMEDCO, IRCON, JBCHEPHARM, MINDACORP, MOTHERSON, NCC, NOVARTIND, OBEROIRLTY, PPLPHARMA PRICOLLTD, RBA, RML, ROSSELLIND, SHREECEM, SKFINDIA, SYMPHONY, TBZ, TDPOWERSYS, TRENT, UNOMINDA

CUMMINSIND YoY:

Net Profit expected to be seen at Rs 263.0 crore versus Rs 241.0 crore 

Revenues expected to be seen at Rs 1969.0 crore versus Rs 1701.0 crore 

EBITDA expected to be seen at Rs 301.0 crore versus Rs 270.0 crore

EBITDA margin expected to be seen at 11.3% versus 11.9%

MOTHERSON YoY:

Net Profit expected to be seen at Rs 454.0 crore versus Rs 245.0 crore 

Revenues expected to be seen at Rs 19426.0 crore versus Rs 16118.0 crore 

EBITDA expected to be seen at Rs 1566.0 crore versus Rs 1076.0 crore

EBITDA margin expected to be seen at 8.0 % versus 6.7%

OBEROI REALTY YoY:

Net Profit expected to be seen at Rs 282.0 crore versus Rs 467.0 crore 

Revenues expected to be seen at Rs 878.0 crore versus Rs 832.0 crore 

EBITDA expected to be seen at Rs 413.0 crore versus Rs 332.0 crore

EBITDA margin expected to be seen at 47.0 % versus 39.9%

SHREECEM YoY:

Net Profit expected to be seen at Rs 351.0 crore versus Rs 482.0 crore 

Revenues expected to be seen at Rs 4142.0 crore versus Rs 3637.0 crore 

EBITDA expected to be seen at Rs 746.0 crore versus Rs 845.0 crore

EBITDA margin expected to be seen at 18.0 % versus 23.2%

TRENT YoY:

Net Profit expected to be seen at Rs 93.0 crore versus Rs 155.0 crore 

Revenues expected to be seen at Rs 2251.0 crore versus Rs 1499.0 crore 

EBITDA expected to be seen at Rs 413.0 crore versus Rs 332.0 crore

EBITDA margin expected to be seen at 18.0 % versus 18.2%

Result Calendar 09.02.2023

AKZOINDIA, ALEMBICLTD, ALKYLAMINE, APTECHT, AUROPHARMA, BAJAJCON, BOMDYEING, BRIGADE, CHOLAHLDNG, DEVYANI, EIHAHOTELS, EXXARO, FDC, FINCABLES, FINEORG, FORCEMOT, GARFIBRES, GREAVESCOT, HAL, HCG, HINDALCO, HINDPETRO, IOB, IRCTC, KALPATPOWR, KIMS, LICI, LUPIN, MRF, NATCOPHARM, NESCO, NIRLON, PAGEIND, PANAMAPET, PARAS, PFIZER, RAINBOW, RITES, SAPPHIRE, TVSSRICHAK, UBL, UJJIVAN, VOLTAS, ZOMATO

 (Disclaimer: The information provided here is investment advice only. Investing in the markets is subject to risks and please consult your advisor before investing.)

(સ્પષ્ટતા: અત્રેથી આપવામાં આવતી તમામ પ્રકારની માહિતી કોઇપણ પ્રકારે રોકાણ, ટ્રેડીંગ માટેની સલાહ નથી. બજારોમાં રોકાણ જોખમોને આધીન છે અને રોકાણ કરતા પહેલા કૃપા કરીને તમારા સલાહકારની સલાહ લો.)